Literature DB >> 24906315

Cell cycle regulation during viral infection.

Sumedha Bagga1, Michael J Bouchard.   

Abstract

To replicate their genomes in cells and generate new progeny, viruses typically require factors provided by the cells that they have infected. Subversion of the cellular machinery that controls replication of the infected host cell is a common activity of many viruses. Viruses employ different strategies to deregulate cell cycle checkpoint controls and modulate cell proliferation pathways. A number of DNA and RNA viruses encode proteins that target critical cell cycle regulators to achieve cellular conditions that are beneficial for viral replication. Many DNA viruses induce quiescent cells to enter the cell cycle; this is thought to increase pools of deoxynucleotides and thus, facilitate viral replication. In contrast, some viruses can arrest cells in a particular phase of the cell cycle that is favorable for replication of the specific virus. Cell cycle arrest may inhibit early cell death of infected cells, allow the cells to evade immune defenses, or help promote virus assembly. Although beneficial for the viral life cycle, virus-mediated alterations in normal cell cycle control mechanisms could have detrimental effects on cellular physiology and may ultimately contribute to pathologies associated with the viral infection, including cell transformation and cancer progression and maintenance. In this chapter, we summarize various strategies employed by DNA and RNA viruses to modulate the replication cycle of the virus-infected cell. When known, we describe how these virus-associated effects influence replication of the virus and contribute to diseases associated with infection by that specific virus.

Entities:  

Mesh:

Year:  2014        PMID: 24906315      PMCID: PMC7122065          DOI: 10.1007/978-1-4939-0888-2_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  372 in total

Review 1.  Regulation of cell cycle re-entry by growth, survival and stress signalling pathways.

Authors:  S J Cook; K Balmanno; A Garner; T Millar; C Taverner; D Todd
Journal:  Biochem Soc Trans       Date:  2000-02       Impact factor: 5.407

2.  The molecular chaperone activity of simian virus 40 large T antigen is required to disrupt Rb-E2F family complexes by an ATP-dependent mechanism.

Authors:  C S Sullivan; P Cantalupo; J M Pipas
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase.

Authors:  R Ohki; J Nemoto; H Murasawa; E Oda; J Inazawa; N Tanaka; T Taniguchi
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

Review 4.  Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control.

Authors:  D J Lew; S Kornbluth
Journal:  Curr Opin Cell Biol       Date:  1996-12       Impact factor: 8.382

5.  Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.

Authors:  Elizabeth Turpin; Kimberly Luke; Jeremy Jones; Terrence Tumpey; Kouacou Konan; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.

Authors:  J A DeCaprio; J W Ludlow; J Figge; J Y Shew; C M Huang; W H Lee; E Marsilio; E Paucha; D M Livingston
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

7.  Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107.

Authors:  H Stubdal; J Zalvide; J A DeCaprio
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

8.  Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A.

Authors:  D E Roopchand; J M Lee; S Shahinian; D Paquette; H Bussey; P E Branton
Journal:  Oncogene       Date:  2001-08-30       Impact factor: 9.867

9.  Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase.

Authors:  Lingyun Li; Bin Gu; Feng Zhou; Jing Chi; Fang Wang; Guangyong Peng; Fangyi Xie; Jian Qing; Dongju Feng; Shiqiang Lu; Kun Yao
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

10.  Human T-cell leukemia virus-I tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response.

Authors:  Abdelali Haoudi; Rodney C Daniels; Eric Wong; Gary Kupfer; O John Semmes
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

View more
  47 in total

1.  Virus-induced cell gigantism and asymmetric cell division in archaea.

Authors:  Junfeng Liu; Virginija Cvirkaite-Krupovic; Diana P Baquero; Yunfeng Yang; Qi Zhang; Yulong Shen; Mart Krupovic
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-13       Impact factor: 11.205

2.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

3.  Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.

Authors:  Ilkyun Im; Ye Seul Son; Kwang Bo Jung; Insoo Kang; Boon-Eng Teh; Kyung-Bok Lee; Mi-Young Son; Janghwan Kim
Journal:  J Biol Chem       Date:  2019-09-30       Impact factor: 5.157

4.  The Severe Fever with Thrombocytopenia Syndrome Virus NSs Protein Interacts with CDK1 To Induce G2 Cell Cycle Arrest and Positively Regulate Viral Replication.

Authors:  Sihua Liu; Hongyun Liu; Jun Kang; Leling Xu; Keke Zhang; Xueping Li; Wen Hou; Zhiyun Wang; Tao Wang
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

5.  Integrated analysis of mRNA-seq and miRNA-seq for host susceptibilities to influenza A (H7N9) infection in inbred mouse lines.

Authors:  Suying Bao; Lilong Jia; Xueya Zhou; Zhi-Gang Zhang; Hazel Wai Lan Wu; Zhe Yu; Gordon Ng; Yanhui Fan; Dana S M Wong; Shishu Huang; Kelvin Kai Wang To; Kwok-Yung Yuen; Man Lung Yeung; You-Qiang Song
Journal:  Funct Integr Genomics       Date:  2018-03-21       Impact factor: 3.410

Review 6.  Role of HBx in hepatitis B virus persistence and its therapeutic implications.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

7.  Characterization of Localization and Export Signals of Bovine Torovirus Nucleocapsid Protein Responsible for Extensive Nuclear and Nucleolar Accumulation and Their Importance for Virus Growth.

Authors:  Makoto Ujike; Yukako Kawachi; Yui Matsunaga; Yuka Etho; Hideki Asanuma; Wataru Kamitani; Fumihiro Taguchi
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

8.  Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication.

Authors:  Mingjun Su; Da Shi; Xiaoxu Xing; Shanshan Qi; Dan Yang; Jiyu Zhang; Yuru Han; Qinghe Zhu; Haibo Sun; Xiaoran Wang; Haoyang Wu; Meijiao Wang; Shan Wei; Chunqiu Li; Donghua Guo; Li Feng; Dongbo Sun
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

9.  ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait ('CoV-MAC-TED') for Combating SARS-CoV-2-Induced Cell Reprogramming.

Authors:  José Hélio Costa; Gunasekaran Mohanapriya; Revuru Bharadwaj; Carlos Noceda; Karine Leitão Lima Thiers; Shahid Aziz; Shivani Srivastava; Manuela Oliveira; Kapuganti Jagadis Gupta; Aprajita Kumari; Debabrata Sircar; Sarma Rajeev Kumar; Arvind Achra; Ramalingam Sathishkumar; Alok Adholeya; Birgit Arnholdt-Schmitt
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

10.  SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.

Authors:  Hua Geng; Saravanan Subramanian; Longtao Wu; Heng-Fu Bu; Xiao Wang; Chao Du; Isabelle G De Plaen; Xiao-Di Tan
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.